Paul D. Rubin, Chief Medical Officer at BioAge Labs, Inc. (BIOA), sold 137,794 shares at $10.19 ($1.4M) on 2025-12-04, disclosed to the SEC on 2025-12-05.
Scheduled sale ($1.4M) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.19 | 68,897 | $702K | 50.0% |
| 2 | $10.19 | 68,897 | $702K | 50.0% |
| Total | $10.19 avg | 137,794 | $1.4M | 100% |
| Filing → |
| BIOA | SELL | 2026-02-03 | $139K | — | Filing → |
| BIOA | SELL | 2026-01-06 | $191K | — | Filing → |
| BIOA | SELL | 2025-12-11 | $216K | — | Filing → |